Results - Announcements
Ajanta Pharma Ltd share price inched up 1.52% to Rs 3512.4 after the company's net profit registered a growth of 16.13% to Rs 388.14 crore, while revenue from operations edged up 10.34% to Rs 1794.16 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, easing 4.48%. It has marginally improved by 6.57% over last one week and crept higher by 1.39% in last one month while the market capitalization of Ajanta Pharma Ltd has improved by 7.05% and 1.24% in the same period respectively.
Profit before tax (PBT) of Ajanta Pharma Ltd stood at Rs 535.15 crore in Q3 FY26, rallying 57.02% year-on-year, and expanding by 19.77% quarter-on-quarter. EBITDA came in at Rs 510 crore, surging by 90.01% YoY and jumping 44.66% sequentially.
Total expenses saw a slight increase of 3.79% to Rs 1294.16 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 348.97 crore, advancing by 17.69% YoY, while employee benefits expense was at Rs 383.69 crore, inching up 0.68% YoY.
For the TTM ended FY26, revenue from operations advanced 17.31% to Rs 5452.86 crore, while net profit expanded by 14.73% to Rs 1056.0 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 119303% to Rs 1222.76 crore, and PBT rose 15.85% to Rs 1377.65 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 529.19 crore in FY26, as against Rs 1157.23 crore in FY25.
Ajanta Pharma Ltd rallied 42.26% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 11.78% during the same period.